Four-Year Weight Loss with Wegovy (Semaglutide 2.4mg) Cardiovascular Study - Part 1
Weight and Healthcare · Ragen Chastain
May 18, 202411m 33s
Audio is streamed directly from the publisher (api.substack.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
As you might imagine, I subscribe to a large number of medical publications and in the last couple of days I’ve been receiving updates from them falling all over themselves to breathlessly claim that weight loss was maintained for 4 years on Semaglutide 2.4mg (aka Wegovy) in the SELECT trial.
The ways in which these claims are misleading are egregious and anti-science. In part 1 I’ll look at the initial claims and the people making them, in part 2 I’ll do a deeper analysis of the study.
Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe